C. Kattamis

Medicine · Health Sciences

25h-index1.5kcitations68works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(43), Iron Metabolism and Disorders(23), Genomics and Rare Diseases(6), Cystic Fibrosis Research Advances(4), Blood groups and transfusion(4)

Publications68 total

The juvenile fibromyalgia syndrome (JFMS): a poorly defined disorder.
PubMed·2019· 29 citedOpen Access
Athens University thalassemia expertise unit: evolution, structure, perspectives and patients' expectations.
PubMed·2013· 3 cited
Study of bone density by pQCT analysis in healthy adults and patients with B-thalassemia major and intermedia.
PubMed·2008· 6 cited
CHELATION THERAPY WITH DEFERASIROX VERSUS DEFEROXAMINE IN TRANSFUSION-DEPENDENT SICKLE-CELL DISEASE: A COST-EFFECTIVENESS ANALYSIS FROM THE US PERSPECTIVE
2006· 2 cited
Deferasirox (Exjade®, ICL670) Demonstrates Iron Chelating Efficacy Related to Transfusional Iron Intake in Pediatric Patients.
Blood·2005· 7 cited
Long term follow up of thalassemic patients with hepatitis C and normal aminotransferases treated with interferon-alpha
Journal of Hepatology·2002
Reactogenicity of DTPa–HBV/Hib vaccine administered as a single injection vs DTPa–HBV and Hib vaccines administered simultaneously at separate sites, to infants at 2, 4 and 6 months of age
Vaccine·2001· 15 cited
Non-invasive myocardial iron assessment in thalassaemic patients: T2 relaxometry and magnetization transfer ratio measurements
Acta Radiologica·2000· 31 cited
NON-INVASIVE MYOCARDIAL IRON ASSESSMENT IN THALASSAEMIC PATIENTS. T2 relaxometry and magnetization transfer ratio measurements
Acta Radiologica·2000· 17 cited
Molecular Studies of β-Thalassemia Heterozygotes with Raised Hb F Levels
Hemoglobin·2000· 21 cited
MUCOEPIDERMOID CARCINOMA OF THE BRONCHUS
Pediatric Hematology and Oncology·2000· 68 cited
Molecular, haematological and clinical studies of the −101 C → T substitution of the β‐globin gene promoter in 25 β‐thalassaemia intermedia patients and 45 heterozygotes
British Journal of Haematology·1999· 45 citedOpen Access
Tissue immunodetection of c100 hepatitis C virus antigen in major thalassemic patients.
PubMed·1999· 1 cited
Prevalence of yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in multitransfused Greek patients with thalassemic syndromes
Clinical Microbiology and Infection·1999· 8 citedOpen Access
Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia
Molecular Human Reproduction·1998· 58 cited
Rare β-Thalassemia Alleles In the Greek and Greek Cypriot Populations
Hemoglobin·1998· 10 cited
Growth and management of short stature in thalassaemia major.
PubMed·1998· 45 cited
An α-Thalassemic Hemoglobinopathy: Homozygosity for the Hb Agrinio α2-Globin Chain Variant
Hemoglobin·1998· 16 cited
Serum Pepsinogen I(Pgi) in Children With Gastritis 64
Pediatric Research·1997Open Access
ASSESSMENT OF THE HEMATOLOGICAL PHENOTYPE IN 34 CARRIERS OF THEβ-THALASSEMIA-101 C>T (SILENT?) MUTATION 111
Pediatric Research·1997Open Access
page 1 of 4Next →

Frequent Co-authors

Emmanuel Kanavakis(14), A Metaxotou-Mavromati(13), Joanne Traeger‐Synodinos(11), Christina Vrettou(6), Maria Tzetis(6), W. G. Wood(6), E. Maragoudaki(4), T. H. J. Huisman(4), Emmanouel Kanavakis(4), D. J. Weatherall(4), Thalia Antoniadi(3), V. Ladis(3), G. Stamatoyannopoulos(3), K. Sofroniadou(3), Ioannis Papassotiriou(3), Th. Michael(2), Evagelia Lagona(2), Ljiljana Janković(2), Г. Д. Ефремов(2), G. Petkov(2)